| Bioactivity | Anti-MRSA agent 15 (Compound 9o10) exhibits antibacterial activity, that inhibits methicillin-resistant Staphylococcus aureus (MRSA) with a MIC of 0.0625 μg/mL. Anti-MRSA agent 15 exhibits low hemolysis and low cytotoxicity. Anti-MRSA agent 15 exhibits anti-infective in mice[1]. |
| Formula | C28H20F2N2O3 |
| Molar Mass | 470.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ma C, et al., Design, synthesis of griseofamine A derivatives and development of potent antibacterial agents against MRSA. Eur J Med Chem. 2024 Jul 22;276:116703. |